HAE:NYSE
Haemonetics Corp
$103.16
arrow_downward
-0.35%(-0.36) 1D
Oct 7, 9:42:17 AM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for HAE...
Open
$103.48
High
$104.02
Low
$103.07
Mkt. cap
4.69B
Avg. vol.
572.37K
Volume
11.94K
P/E ratio
50.31
52-wk high
$110.45
52-wk low
$48.17
EPS
$2.05
Beta
0.61
Shares outstanding
45.50M
No. of employees
3K
Open
$103.48
High
$104.02
Low
$103.07
Mkt. cap
4.69B
Avg. vol.
572.37K
Volume
11.94K
P/E ratio
50.31
52-wk high
$110.45
52-wk low
$48.17
EPS
$2.05
Beta
0.61
Shares outstanding
45.50M
No. of employees
3K
News stories
From web sources and news partners
AD HOC NEWS
·
13 hours ago
Haemonetics stock heads toward its November 5 results
Zacks
·
1 day ago
PAHC vs. HAE: Which Stock Is the Better Value Option?
Benzinga
·
2 days ago
Haemonetics Q1 2027 Earnings Call Transcript
AD HOC NEWS
·
2 days ago
Haemonetics stock heads into November 5 results with key benchmarks
Profile
Haemonetics Corporation is a global provider of blood and plasma supplies and services. The company was founded in Natick, Massachusetts by Dr. Allen Latham in the 1970s.
Today, the company has expanded and has offices located in 16 countries. The company employs more than 1,800 people and markets its products in over 50 countries. Revenue is derived nearly equally from its three major markets -- Asia, Europe, and the Americas. Wikipedia
About Haemonetics Corp
CEOChristopher Simon
Employees3.01K
Founded1971
HeadquartersBoston, Massachusetts, United States
SectorMedical device
Websitehaemonetics.com